NeuroVive Pharmaceutical AB SMA 50
¿Qué es el SMA 50 de NeuroVive Pharmaceutical AB?
El SMA 50 de NeuroVive Pharmaceutical AB es $0 +0.00%
¿Cuál es la definición de SMA 50?
SMA 50 es un precio promedio de las acciones de los últimos 50 días calculado como una media no ponderada de los previos 50 precios de cierre de acciones.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 de compañías en Sector Health Care en OTC en comparadas con NeuroVive Pharmaceutical AB
¿Qué hace NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Empresas con sma 50 similar a NeuroVive Pharmaceutical AB
- Enerev5 Metals tiene SMA 50 de CAD$0 -93.75%
- Monarca Minerals tiene SMA 50 de CAD$0 -93.75%
- Sorrento Therapeutics Inc tiene SMA 50 de $0 +3.13%
- AusCann tiene SMA 50 de $0 -155.18%
- Auris Minerals tiene SMA 50 de AUD$0 -94.12%
- Surefire Resources NL tiene SMA 50 de AUD$0 -38.89%
- NeuroVive Pharmaceutical AB tiene SMA 50 de $0 +0.00%
- Forbidden Foods tiene SMA 50 de $0 +6.49%
- Accelerate Resources tiene SMA 50 de AUD$0 -14.58%
- Rodedawg International Industries tiene SMA 50 de $0 -71.88%
- E2Gold tiene SMA 50 de CAD$0 -3.85%
- Propell Ltd tiene SMA 50 de $0 +18.68%
- Shanghai Zendai Property tiene SMA 50 de HKD$0 +18.41%